Chart of the Day: The Trump Plan for Prescription Drugs

After griping for hours about President Trump’s upcoming speech on reducing prescription drug prices, you’d think I’d at least listen to the damn thing and then comment on it, wouldn’t you? I guess so. That would be the fair thing to do.

But here’s the thing: Sometimes I get tired of being sucked into long, dry analyses of Republican plans that we all know perfectly well are meaningless. Someone has to do it, and very often that someone is me. It’s my role in the vast politico-industrial complex, after all. But seriously, who cares? Trump himself barely understood what he was reading, and whatever it was, Congress is going to ignore it. Plus it’s Friday, and I’m tired. So fuck it.

Besides, there’s really no need for all that work. There are hundreds of analysts out there who know more than me about this stuff, and they render instant decisions on it via the stock market. So if all you want to know is whether Trump’s plan is good for consumers or good for pharmaceutical companies, just check out how pharmaceutical stocks did as Trump was delivering his speech. If stocks went down, that’s good news for consumers. If stocks went up, it’s good news for drug companies.

Can you guess which way pharmaceutical stocks went? Huh? Can you?

Fact:

In-depth journalism that investigates the powerful takes real money and is so damn important right now.But it doesn’t take a Mother Jones investigation to know that billionaires and corporations will never fund the type of reporting (like they do politicians) we do that exists to help bring about change. Instead, our mission-driven journalism is made possible by people power, and has been for 46 years now since our founding as a non-profit.

In “TITLE TK” Monica Bauerlein writes about the perilous moment we’re in, and why it’s so important that we raise $325,000 by the time November’s midterms are decided so we can be ready to throw everything we have at the big issues facing the nation no matter what happens. Please help MoJo’s people-powered journalism with a donation today.

$400,000 to go!

payment methods

Fact:

In-depth journalism that investigates the powerful takes real money and is so damn important right now.But it doesn’t take a Mother Jones investigation to know that billionaires and corporations will never fund the type of reporting (like they do politicians) we do that exists to help bring about change. Instead, our mission-driven journalism is made possible by people power, and has been for 46 years now since our founding as a non-profit.

In “TITLE TK” Monica Bauerlein writes about the perilous moment we’re in, and why it’s so important that we raise $325,000 by the time November’s midterms are decided so we can be ready to throw everything we have at the big issues facing the nation no matter what happens. Please help MoJo’s people-powered journalism with a donation today.

$400,000 to go!

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate